| For: | Shi YW, Yang RX, Fan JG. Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. World J Gastroenterol 2021; 27(26): 3971-3983 [PMID: 34326608 DOI: 10.3748/wjg.v27.i26.3971] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i26/3971.htm |
| Number | Citing Articles |
| 1 |
Sofie Jespersen, Peter Plomgaard, Sten Madsbad, Adam Espe Hansen, Thomas Bandholm, Bente Klarlund Pedersen, Christian Ritz, Nina Weis, Rikke Krogh-Madsen. Effect of aerobic exercise training on the fat fraction of the liver in persons with chronic hepatitis B and hepatic steatosis: Trial protocol for a randomized controlled intervention trial— The FitLiver study. Trials 2023; 24(1) doi: 10.1186/s13063-023-07385-y
|
| 2 |
Lili Zhang, Yuming Li, Ying Li. Circulating citrate as a mediator in the relationship between HMGCR inhibitors and chronic hepatitis B: a Mendelian randomization study. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95100-z
|
| 3 |
Rushi V. Mukkawar, Nishant Rathod, Rajvardhan Patil, Sunil Kumar, Sourya Acharya. Impact of fatty liver disease on hepatic function and fibrosis progression in chronic hepatitis B patients: a narrative review. International Journal of Nutrition, Pharmacology, Neurological Diseases 2025; 15(4) doi: 10.4103/ijnpnd.ijnpnd_46_25
|
| 4 |
Ying Zheng, Xiao-Wei Wang, Chen-Xi Xia. Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B. World Journal of Psychiatry 2023; 13(10): 753-762 doi: 10.5498/wjp.v13.i10.753
Abstract(989) |
Core Tip(985) |
Full Article(HTML)(2905)
|
Full Article (PDF)-804K(230)
|
Full Article with Cover (PDF)-1022K(279)
|
Full Article (Word)-396K(72)
|
Full Article (XML)-88K(189)
|
Audio-1584K(27)
|
Peer-Review Report-227K(151)
|
Answering Reviewers-59K(142)
|
Times Cited (6)
|
Total Visits (5040)
|
Open
|
| 5 |
Hee Jun Park, Hyo Jeong Kang, So Yeon Kim, Seonghun Yoon, Seunghee Baek, In Hye Song, Hyeon Ji Jang, Jong Keon Jang. Effects of hepatic fibrosis on the quantification of hepatic steatosis using the controlled attenuation parameter in patients with chronic hepatitis B. Ultrasonography 2025; 44(1) doi: 10.14366/usg.24138
|
| 6 |
Xue-cheng Tong, Kai Liu, Ze-yu Huang, Xiu-jun Zhang, Yuan Xue. Obesity has causal effects on chronic hepatitis B but CHB has no causal effect on obesity: evidence from a Mendelian randomization study. Critical Public Health 2025; 35(1) doi: 10.1080/09581596.2025.2521449
|
| 7 |
Ying Luo, Zhenhua Dong, Suying Qi, Weiguo Li. Application of Health Education Model Based on Theory of Behavior Change in Nursing Care of Patients with Chronic Hepatitis B. Journal of Nanomaterials 2022; 2022(1) doi: 10.1155/2022/1982554
|
| 8 |
Alexa Keeshan, Carolina Fernandes da Silva, Alicia Vachon, Elizabeth Giles, Carla Osiowy, Carla Coffin, Curtis L. Cooper. Hepatitis B Virus Genotype Influence on Virological and Enzymatic Measures over Time—A Retrospective Longitudinal Cohort Study. Journal of Clinical Medicine 2023; 12(21) doi: 10.3390/jcm12216807
|
| 9 |
Run Zhou, Luping Yang, Binbin Zhang, Yunpeng Gu, Tingting Kong, Wei Zhang, Lei Sun, Chunlan Liu, Ningjia Kong, Jie Li, Junping Shi. Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2023; 30(10) doi: 10.1111/jvh.13872
|
| 10 |
Sitong Yi, Guanghui Ren, Ying Zhu, Qingwei Cong. Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study. Virology Journal 2024; 21(1) doi: 10.1186/s12985-023-02277-8
|
| 11 |
Nasser Abdallah, Khaled Hussain, Akram Deghady, Samar Raky, Marwa Deif. Validity of serum CCL11 (Eotaxin-1) and interleukin-13 as prognostic biomarkers in hepatitis C virus induced liver disease. The Egyptian Journal of Internal Medicine 2026; 38(1) doi: 10.1186/s43162-026-00625-y
|
| 12 |
Fadi Abu Baker, Saif Abu Mouch, Dorin Nicola, Randa Taher Natour, Oren Shibolet. Predictors for significant hepatic fibrosis in chronic HBV patients in daily clinical practice: A prospective study. Journal of Investigative Medicine 2025; 73(5) doi: 10.1177/10815589251331892
|
| 13 |
Yanping Huang, Lu Liu, Jingru Song, Dengcheng Hui, Lanfeng Xie, Silan Shen, Yulang Jiang, Dan Wang, Hongyan Cao, Yancheng Dai, Mingmei Zhou, Qin Zhang, Mingyu Sun. The regulatory effects of Yinchen Wuling powder on chronic Hepatitis B patients with NAs by integrating network pharmacology and metabolomics: A randomized -controlled clinical study. Advances in Integrative Medicine 2026; 13(1) doi: 10.1016/j.aimed.2026.100612
|
| 14 |
Feng Chen, Yingxia Liu, Qianhui Li, Fei Wang. Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis/hepatitis B - induced hepatic injury. Clinics and Research in Hepatology and Gastroenterology 2023; 47(1) doi: 10.1016/j.clinre.2022.102056
|
| 15 |
Huiqing Liang, Yizhi Xie, Yan Dai, Xiaorong Yang, Xiaoting Zheng, Jiaen Yang, Yaoyu Liu, Chuncheng Wu, Siyan Chen, Manying Zhang, Hongli Zhuang, Li Lin, Shaodong Chen, Peter Pelka. Impact of nonalcoholic fatty liver disease on the response to pegylated interferon-α therapy in patients with chronic hepatitis B. Microbiology Spectrum 2026; doi: 10.1128/spectrum.03424-25
|
| 16 |
Pei-Yi Chu, Chang-Lu Hsu, Yen-An Lin, Yi-Cheng Pan, Yun-Hao Dai, Ying-Chun Yu, Juan-Cheng Yang, Wen-Lung Ma, Yi-Jinn Lillian Chen, Chia-Lin Lee, Yang-Chang Wu. Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice. Heliyon 2024; 10(2) doi: 10.1016/j.heliyon.2024.e24438
|
| 17 |
Zhiyuan Chen, Ye Huang, Yan Zhang, Dongjing Zhou, Yu Yang, Shuping Zhang, Huanming Xiao, HaiXia Li, Yupin Liu. Impact of hepatic steatosis on liver stiffness measurement by vibration-controlled transient elastography and its diagnostic performance for identifying liver fibrosis in patients with chronic hepatitis B. Insights into Imaging 2024; 15(1) doi: 10.1186/s13244-024-01857-8
|
| 18 |
Mu-Chi Chung, Tung-Min Yu, Laing-You Wu, Ming-Ju Wu, Jeng-Jer Shieh, Chi-Jung Chung. SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis. JAMA Network Open 2026; 9(2) doi: 10.1001/jamanetworkopen.2025.60429
|
| 19 |
Zihan Zhou, Zhuo Bai, Chang Zheng, Jing Wu, Lan Li, Aibin Cheng, Xiuli Men. Association between coronary artery disease and viral hepatitis: Perspectives based on the 2017–2018 National Health and Nutrition Examination Survey and Mendelian randomization analyses. Medicine 2026; 105(23) doi: 10.1097/MD.0000000000049202
|
| 20 |
Xin Cai, Shi Peng, Xuan Xiao, Zhaoyang Huang, Pingan Zhang. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61820-x
|
| 21 |
Dongcang Hou, Fei Liu, Dongjie Hou, Chunrong Ping, Wenying He, Zeyang Chen, Ganlu Tian, Tian Qin, Wenjing Zhou, Menghui Xu, Xiaoman Ruan. Effects of phased focused nursing on liver function and self-care ability in chronic hepatitis B patients. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1679180
|
| 22 |
Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi, Liang Xu. A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.862879
|
| 23 |
Feng He, Zhongjiang Xia, Hui Wang, Jinjun Zhu, Laiwen Hu, Zhaoqi Dong. Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/1673453
|
| 24 |
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Melanie Deutsch, Georgios Aloizos, Sotirios P. Fortis, Effie G. Papageorgiou, Ariadne Tsagarakis, Spilios Manolakopoulos. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management. International Journal of Molecular Sciences 2022; 23(20) doi: 10.3390/ijms232012185
|
| 25 |
Qianqian Zhu, Chengde Su, Mingdan Li, Yali Xu, Qian Liu, Ying Zhang, Xinyi Zhang, Qiuxiang Li, Huajun Wang, Yawen Luo, Ping Yang. Impact of Metabolic Dysfunction-Associated Fatty Liver Disease of Varying Severity on Antiviral Treatment Outcomes and Clinical Prognosis in Patients with Chronic Hepatitis B: A Systematic Review and Meta-analysis. Infectious Diseases and Therapy 2025; 14(8) doi: 10.1007/s40121-025-01189-0
|
| 26 |
Patients with acute liver failure due to hepatitis B: a case report. International Journal of Advances in Medicine 2025; 12(3) doi: 10.18203/2349-3933.ijam20251080
|
| 27 |
Lin Chen, Xuemei Tao, Minghui Zeng, Yuqin Li, Jiaxin Han, Yuekui Wang, Yonggang Liu, Ruifang Shi, Rui Su, Liang Xu, Yuqiang Mi. Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease. Journal of Medical Virology 2024; 96(4) doi: 10.1002/jmv.29613
|
| 28 |
Laura Žigutytė, Thomas Sorz-Nechay, Jan Clusmann, Jakob Nikolas Kather. Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024. JHEP Reports 2024; 6(12) doi: 10.1016/j.jhepr.2024.101209
|
| 29 |
Chuyang Wang, Yutao Chen, Huanming Xiao, Jianxiong Cai, Ruihua Wang, Xuan Zeng, Ming Lin, Wofeng Liu, Xiaoling Chi, Qubo Chen, Yury E Khudyakov. Metabolomics-guided machine learning reveals diagnostic and mechanistic biomarkers in CHB with MASLD. PLOS One 2026; 21(2) doi: 10.1371/journal.pone.0331529
|
| 30 |
Nishi H. Patel, Aaron Lucko, Alicia Vachon, Karen E. Doucette, Alnoor Ramji, Laura Sycuro, Trushar R. Patel, Kris Chadee, Maitreyi Raman, Guido van Marle, Carla Osiowy, Carla S. Coffin. Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease. Journal of Viral Hepatitis 2024; 31(10) doi: 10.1111/jvh.13979
|
| 31 |
Ghani Israr, Qinqin Qiao, Yuxuan An, Fengming Liu, Zhuoyu Li. From Mycobiome Remodeling to Therapeutic Candidate: Aspergillus ruber and 3-methyldioxyindole, Acknowledged as a Novel Modulator Via BPIS Treatment and Alleviating MASLD. Probiotics and Antimicrobial Proteins 2026; 18(4) doi: 10.1007/s12602-025-10843-5
|
| 32 |
Aoyun Hao, Changlei Li, Ruitao Sun, Bin Tan, Guanming Shao, Kun Li, Na Li, Weiyu Hu, Chao Qu, Jingyu Cao. Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S536629
|
| 33 |
Pengyan Zhang, Zhenqiu Liu, Hong Fan, Tingting Shi, Xinyu Han, Chen Suo, Xingdong Chen, Tiejun Zhang. Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2023; 35(3) doi: 10.1097/MEG.0000000000002488
|
| 34 |
Anne-Marieke Van Dijk, Cas Isfordink, Anders Boyd, Henrike Galenkamp, Janke Schinkel, Maria Prins, R.Bart Takkenberg, Onno Holleboom, Marc Van Der Valk. Targeted Screening for Viral Hepatitis Among Various Ethnic Groups in Amsterdam, the Netherlands. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-136838
|
| 35 |
Carlo Acierno, Riccardo Nevola, Fannia Barletta, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Alfredo Caturano. Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship. Biomedicines 2025; 13(6) doi: 10.3390/biomedicines13061343
|
| 36 |
|
| 37 |
Minako Yuri, Takashi Nishimura, Toshifumi Tada, Masahiro Yoshida, Aoi Fujiwara, Shoki Kawata, Kohei Yoshihara, Ryota Yoshioka, Shogo Ota, Ryota Nakano, Yukihisa Yuri, Tomoyuki Takashima, Nobuhiro Aizawa, Naoto Ikeda, Hideyuki Shiomi, Yoshi‐Hiro Ide, Hirayuki Enomoto, Fujimoto Yasuhiro, Hirohisa Yano, Hiroko Iijima. Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis. Hepatology Research 2022; 52(12) doi: 10.1111/hepr.13831
|
| 38 |
Zhenqiu Liu, Yanfeng Jiang, Chen Suo, Huangbo Yuan, Ziyu Yuan, Tiejun Zhang, Li Jin, Xingdong Chen. Cohort Profile: Taizhou Study of Liver Diseases (T-SOLID). International Journal of Epidemiology 2025; 54(2) doi: 10.1093/ije/dyaf030
|
| 39 |
Jiayi Huang, Sujuan Zhou, Chengnan Guo, Xin Zhang, Shuzhen Zhao, Luojia Dai, Zhenqiu Liu, Tiejun Zhang. Prevalence and clinical characteristics of concurrent chronic hepatitis B and fatty liver disease in China: a systematic review and meta-analysis. BMC Public Health 2025; 26(1) doi: 10.1186/s12889-025-25816-0
|
| 40 |
Stephanos Vassilopoulos, Markos Kalligeros, Athanasios Vassilopoulos, Fadi Shehadeh, Gregorio Benitez, Matthew Kaczynski, Ingrid Lazaridou, Kittichai Promrat, Jack R. Wands, Eleftherios Mylonakis. Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease. Journal of Viral Hepatitis 2023; 30(8) doi: 10.1111/jvh.13862
|
| 41 |
Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher, Saif Abu Mouch, Ariel Israel. Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study. Journal of Clinical Medicine 2024; 13(18) doi: 10.3390/jcm13185608
|
| 42 |
Ran Lu, Ye Liu, Tianpei Hong. Epidemiological characteristics and management of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in China: A narrative review. Diabetes, Obesity and Metabolism 2023; 25(S1) doi: 10.1111/dom.15014
|
| 43 |
Yun-Feng Yu, Gang Hu, Ke-Ke Tong, Xin-Yu Yang, Jing-Yi Wu, Rong Yu. Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study. World Journal of Diabetes 2024; 15(2): 220-231 doi: 10.4239/wjd.v15.i2.220
Abstract(679) |
Core Tip(1083) |
Full Article(HTML)(3095)
|
Full Article (PDF)-1562K(288)
|
Full Article with Cover (PDF)-1899K(225)
|
Full Article (Word)-1009K(45)
|
Full Article (XML)-134K(171)
|
Audio-1806K(12)
|
Peer-Review Report-202K(175)
|
Answering Reviewers-112K(168)
|
Supplementary Material-368K(180)
|
Times Cited (3)
|
Total Visits (4959)
|
Open
|